全文获取类型
收费全文 | 101587篇 |
免费 | 7801篇 |
国内免费 | 391篇 |
专业分类
耳鼻咽喉 | 1130篇 |
儿科学 | 2583篇 |
妇产科学 | 1691篇 |
基础医学 | 14387篇 |
口腔科学 | 2195篇 |
临床医学 | 10417篇 |
内科学 | 21208篇 |
皮肤病学 | 1807篇 |
神经病学 | 10900篇 |
特种医学 | 4225篇 |
外国民族医学 | 12篇 |
外科学 | 14688篇 |
综合类 | 1276篇 |
一般理论 | 73篇 |
预防医学 | 7756篇 |
眼科学 | 1763篇 |
药学 | 7017篇 |
中国医学 | 112篇 |
肿瘤学 | 6539篇 |
出版年
2023年 | 530篇 |
2022年 | 423篇 |
2021年 | 1728篇 |
2020年 | 1325篇 |
2019年 | 1984篇 |
2018年 | 2447篇 |
2017年 | 1798篇 |
2016年 | 2141篇 |
2015年 | 2492篇 |
2014年 | 3285篇 |
2013年 | 4325篇 |
2012年 | 6733篇 |
2011年 | 6784篇 |
2010年 | 4005篇 |
2009年 | 3643篇 |
2008年 | 5952篇 |
2007年 | 6472篇 |
2006年 | 6005篇 |
2005年 | 5949篇 |
2004年 | 5554篇 |
2003年 | 4981篇 |
2002年 | 4910篇 |
2001年 | 1904篇 |
2000年 | 1803篇 |
1999年 | 1627篇 |
1998年 | 1054篇 |
1997年 | 868篇 |
1996年 | 690篇 |
1995年 | 828篇 |
1994年 | 691篇 |
1993年 | 640篇 |
1992年 | 1169篇 |
1991年 | 1091篇 |
1990年 | 1031篇 |
1989年 | 984篇 |
1988年 | 872篇 |
1987年 | 827篇 |
1986年 | 857篇 |
1985年 | 839篇 |
1984年 | 672篇 |
1983年 | 588篇 |
1982年 | 562篇 |
1981年 | 457篇 |
1980年 | 389篇 |
1979年 | 520篇 |
1978年 | 406篇 |
1977年 | 376篇 |
1975年 | 329篇 |
1974年 | 359篇 |
1973年 | 355篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
5.
6.
7.
Rizzo Manglio Miguel Bluthgen Mara Virginia Recondo Gonzalo Naveira Martin Perfetti Aldo Rizzi Florencia Kuzminin Alejandro Faura Victoria Cerini Matas Videla Alejandro Silva Carlos Lupinacci Lorena Minatta Nicols 《International journal of clinical oncology / Japan Society of Clinical Oncology》2021,26(6):1057-1064
International Journal of Clinical Oncology - Immune-checkpoint inhibitors (ICIs) are standard treatments for metastatic non-small cell lung cancer (NSCLC). Patients with poor performance status... 相似文献
8.
Mariantonieta Tirado Sheila M. Dobin Martin P. Fernandez Arundhati Rao 《Journal of cutaneous pathology》2021,48(1):116-122
A 21‐year‐old female presented with a 5‐year history of an erythematous papule on her right breast. The biopsy showed a dense, dermal nodular infiltrate, extending focally into the subcutaneous tissue. The infiltrate was composed predominantly of pleomorphic cells with bi‐lobed, multi‐lobed, horseshoe, or ring‐shaped nuclei. There was a smaller subset of monomorphous cells characterized by a round, reniform, or elongated single‐lobed nucleus. Accompanying cells included few foamy histiocytes, lymphocytes, and numerous scattered eosinophils. No necrosis, vascular invasion, or ulceration was present. The pleomorphic and monomorphic granular cells were positive for Giemsa stain as well as for tryptase, CD117, CD68, CD2, and CD30 immunohistochemistry and negative for S100, CD1a, myeloperoxidase, lysozyme, and CD56. Clinical examination was negative for any additional similar lesions and serum tryptase was within normal limits. The bone marrow was not biopsied. In addition, fluorescent in situ hybridization revealed multiple clones with loss of number 5 chromosome and PDGFRA and HRAS mutations. The lesion did not recur or progress after a 6‐year clinical follow‐up. To our full knowledge, we report the first case of pleomorphic mastocytoma with loss of chromosome 5 and PDGFRA and HRAS mutations. 相似文献
9.
Neal Bhutiani Elizabeth H. Bruenderman Jordan M. Jones John H. Wehry Michael E. Egger Prejesh Philips Charles R. Scoggins Kelly M. McMasters Robert C.G. Martin 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2021,23(1):63-70
BackgroundThe optimal timing of treatment of liver metastases from low-grade neuroendocrine tumors (LG-NELM) varies significantly due to numerous treatment modalities and the literature supporting various treatment(s). This study sought to create and validate a literature-based treatment algorithm for LG-NELM.MethodsA treatment algorithm to maximize overall survival (OS) was designed using peer-reviewed articles evaluating treatment of LG-NELM. This algorithm was retrospectively applied to patients treated for LG-NELM at our institution. Deviation was determined based on whether or not a patient received treatment consistent with that recommended by the algorithm. Patients who did and did not deviate from the algorithm were compared with respect to OS and number of treatments.ResultsApplying our algorithm to a 149-patient cohort, 57 (38%) deviated from recommended treatment. Deviation occurred in the form of alternative (28, 49%) versus additional procedures (29, 51%). Algorithm deviators underwent significantly more procedures than non-deviators (median 1 vs. 2, p < 0.001). Cox model indicated no difference in OS associated with algorithm deviation (HR 1.19, p = 0.58) when controlling for age and tumor characteristics.ConclusionThis literature-based algorithm helps standardize treatment protocols in patients with LG-NELM and can reduce cost and risk by minimizing unnecessary procedures. Prospective implementation and validation is required. 相似文献